Brigatinib

Overview

Brigatinib (AP-26113) is a highly potent, selective and orally active ALK inhibitor, with an IC 50 of 0.6 nM. Brigatinib can be used for research of NSCLC.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Lung Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > Anaplastic lymphoma kinase (ALK)

Product Information

• Catalog No.: HY-12857
• CAS No.: 1197953-54-0
• Molecular Formula: C29H39ClN7O2P
• Molecular Weight: 584.09
• Purity: 99.97%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1 mg/mL (1.71 mM); Clear solution
• Availability: In-stock

Source

Original product source